Perkant Tech was founded in June 2020 and develops Abhay Parimiti, a seven-inch-screen portable device the company describes as an AI-integrated system that analyses over 700 body signals to produce an automated health assessment in under 60 seconds. The company lists the device price at Rs 20,000 and says it manufactures from facilities in Madhya Pradesh and Andhra Pradesh. Perkant claims the system provides instant indicators across cardiac and respiratory health and for measures such as pre-diabetes, glucose, haemoglobin and bilirubin, and markets the platform as a ‘digital doctor’ and a multi-disease prognosis range. The firm holds a granted Indian patent and has filed a U.S. patent application; however, the articles note no peer-reviewed clinical validation and no public evidence of clearance from India’s medical device regulator. Perkant reported successful pilots and a planned commercial launch, but the articles state there are no publicly reported customers, deployments or revenue. The company participated in the Qualcomm Women Entrepreneurs India Network cohort and showcased the device at Nokia’s 6G laboratory event, with six employees listed in mid-2024.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2026